[
  {
    "ts": "2025-11-06T05:38:32+00:00",
    "headline": "The 5 Most Interesting Analyst Questions From DexCom’s Q3 Earnings Call",
    "summary": "DexCom's third quarter was met with a negative market reaction despite outpacing Wall Street’s revenue and adjusted EPS expectations. Management attributed quarterly growth to increased continuous glucose monitoring (CGM) adoption among people with type 2 diabetes, particularly following expanded insurance coverage and deeper reach into primary care. Interim CEO Jacob Leach emphasized the impact of new product features and improved access, but also acknowledged lingering manufacturing and sensor",
    "url": "https://finance.yahoo.com/news/5-most-interesting-analyst-questions-053832165.html",
    "source": "StockStory",
    "provider": "yfinance",
    "raw": {
      "id": "2f6429be-f3a8-3c15-8a82-bda811052edc",
      "content": {
        "id": "2f6429be-f3a8-3c15-8a82-bda811052edc",
        "contentType": "STORY",
        "title": "The 5 Most Interesting Analyst Questions From DexCom’s Q3 Earnings Call",
        "description": "",
        "summary": "DexCom's third quarter was met with a negative market reaction despite outpacing Wall Street’s revenue and adjusted EPS expectations. Management attributed quarterly growth to increased continuous glucose monitoring (CGM) adoption among people with type 2 diabetes, particularly following expanded insurance coverage and deeper reach into primary care. Interim CEO Jacob Leach emphasized the impact of new product features and improved access, but also acknowledged lingering manufacturing and sensor",
        "pubDate": "2025-11-06T05:38:32Z",
        "displayTime": "2025-11-06T05:38:32Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/stockstory_922/c5400de7e48b56a1300bdfbbcf0d0445",
          "originalWidth": 1400,
          "originalHeight": 700,
          "caption": "DXCM Cover Image",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/udhbB0cHnVJO4WPtUvUsrA--~B/aD03MDA7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/stockstory_922/c5400de7e48b56a1300bdfbbcf0d0445.cf.webp",
              "width": 1400,
              "height": 700,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/OPrVhYWO.9SMzT6mgJAbDQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/stockstory_922/c5400de7e48b56a1300bdfbbcf0d0445.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "StockStory",
          "url": "https://stockstory.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/5-most-interesting-analyst-questions-053832165.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/5-most-interesting-analyst-questions-053832165.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "DXCM"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]